FOXP1 and diffuse large B-cell lymphoma: Studies involving B-cell receptor signaling and nuclear factor-κB pathway mutations show that multiple genes can be targeted to deregulate the activity of a pathway or biological process and that individual tumors achieve this in various ways.35, 36, 37 Thus further analyses were performed to identify biological processes associated with FOXP1 target genes that may be regulated by FOXP1 and their conservation or variation between DLBCL subtypes.